HA: female GU Exam

Overview of the Female Genitourinary Exam

  • Focuses on normal anatomy, evidence-based exam techniques, documentation, and cervical cancer screening.

Anatomy Review

  • Vulva Anatomy:

    • Includes mons pubis, labia majora, labia minora, clitoris, perineum.

    • Hymen is normally patent and does not break during intercourse.

    • Important for it to be tested for patentcy in newborns.

  • Pelvic Floor Anatomy:

    • Comprises muscles including bladder, rectum, and vagina.

    • Muscular tension can impact patient symptoms.

  • Uterus and Cervix:

    • Cervix opening (os) varies based on childbirth history, affecting examination.

    • Glandular cells can be found at the squamocolumnar junction, which may vary across patients.

Evidence-Based Exam Techniques

  • Preparation:

    • Ensure patient comfort: ask permission, provide chaperone, explain the process, and allow for patient control.

  • Speculum Selection:

    • Use appropriate size/speculum type (Peterson vs. Graves) and warm the speculum for comfort.

  • Exam Steps:

    • Conduct an external examination, internal via speculum, and bimanual exam to assess various reproductive structures, including the cervix and uterus.

    • Rectovaginal exams are now not routinely part of physical exams unless indicated.

Documentation of Findings

  • External Examination:

    • Note inguinal lymphadenopathy, identify any abnormal lesions/discharge.

  • Bimanual Exam:

    • Document the size, shape, position, and tenderness of the uterus and any associated masses.

Cervical Cancer Screening Guidelines

  • Cervical Cancer Screening Goals:

    • Early detection of precancerous changes to prevent cervical cancer.

  • HPV and Pap Testing:

    • Routine Pap smears begin at age 21; HPV primary screening recommended at age 25.

    • Enhanced screening methods: Pap every 3 years or co-testing every 5 years for those 30+.

  • Risk Factors:

    • Includes immunosuppression, prior treatments, and synthetic estrogen exposure.

    • Cervical cancer screenings can cease at age 65 if previous results are normal.

HPV Vaccine Information

  • Gardasil 9:

    • Approved for ages 9-45, prevents various cancers including cervical, anal, and head/neck cancers.

    • Encourage vaccination in patients up to age 45; often covered by insurance.